ACM
AMPE

ACT Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

ACT Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-972
Closed -$49K – 88
2022
Q2 		$49K Hold
972
– – 0.07% 64
2022
Q1 		$137K Hold
972
– – 0.14% 62
2021
Q4 		$166K Hold
972
– – 0.12% 71
2021
Q3 		$484K Hold
972
– – 0.25% 61
2021
Q2 		$487K Buy
+972
New +$522K 0.25% 68

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

ACT Capital Management's AMPE Position: Q3 2022 in Review

ACT Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 972 shares — an estimated $49K sold.

ACT Capital Management first reported a position in AMPE in Q2 2021 and held it in 5 quarters. The position peaked at $487K in Q2 2021. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • ACT Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • ACT Capital Management sold 972 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $49K.
  • ACT Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 5 quarters.
  • ACT Capital Management's Ampio Pharmaceuticals Inc. position peaked at $487K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.